Nordea Investment Management Boosts ResMed Stake by 37%

The investment firm now owns over 1 million shares of the medical equipment provider.

Mar. 22, 2026 at 10:08am

Got story updates? Submit your updates here. ›

Nordea Investment Management AB increased its position in ResMed Inc. (NYSE:RMD) by 37.2% during the 4th quarter, according to a recent SEC filing. The firm now owns 1,084,996 shares of the medical equipment provider's stock, valued at $262,027,000 and representing a 0.74% ownership stake.

Why it matters

ResMed is a leading manufacturer of sleep apnea and respiratory care devices, an industry that has seen growing demand as awareness of sleep disorders increases. Nordea's increased investment signals confidence in ResMed's long-term growth potential.

The details

Nordea Investment Management acquired an additional 294,124 shares of ResMed during the fourth quarter, bringing its total position to over 1 million shares. The investment firm now owns 0.74% of ResMed's outstanding stock. ResMed's products, which include CPAP machines and other sleep therapy equipment, have seen strong sales growth as the prevalence of sleep apnea has risen.

  • Nordea Investment Management increased its ResMed stake during the 4th quarter of 2025.

The players

Nordea Investment Management AB

A major European asset management firm that has increased its stake in medical device company ResMed Inc.

ResMed Inc.

A global medical device company that develops and manufactures products for the treatment of sleep apnea and other respiratory conditions.

Got photos? Submit your photos here. ›

The takeaway

Nordea's increased investment in ResMed reflects the growing importance of sleep apnea treatment devices as awareness of the condition rises. ResMed's market-leading position makes it an attractive long-term holding for major institutional investors.